No abstract available
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Forecasting*
-
Humans
-
Male
-
Prostate-Specific Antigen
-
Prostatic Neoplasms, Castration-Resistant / drug therapy*
-
Risk Factors
-
Withholding Treatment*
Substances
-
Prostate-Specific Antigen